Genprex

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.28-$14.40
Market Cap
$9.6M
Shares Short
363,385

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$10.69

News

See more

Yahoo Finance • last year

IBN Announces Latest Episode of The Bell2Bell Podcast featuring CEO Rodney Varner & CFO Ryan Confer of Genprex, Inc.

Yahoo Finance • 2 years ago

Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer

Yahoo Finance • 3 years ago

Genprex Announces the Opening for Enrollment of its Phase 1/2 Acclaim-2 Clinical Trial of REQORSA™ Immunogene Therapy in Combination With Keytruda® to Treat Non-Small Cell Lung Cancer

About

CEO
Mr. Ryan M. Confer M.S.
CFO
Mr. Ryan M. Confer M.S.
Address
3300 Bee Cave Road, Austin, TX, United States, 78746
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
21